104 related articles for article (PubMed ID: 38713157)
1. The prognostic value and immunological role of MVP in pan-cancer study.
Li C; Gao M; Zha N; Guo G
Aging (Albany NY); 2024 May; 16(10):8497-8510. PubMed ID: 38713157
[TBL] [Abstract][Full Text] [Related]
2. Major vault protein suppresses lung cancer cell proliferation by inhibiting STAT3 signaling pathway.
Bai H; Wang C; Qi Y; Xu J; Li N; Chen L; Jiang B; Zhu X; Zhang H; Li X; Yang Q; Ma J; Xu Y; Ben J; Chen Q
BMC Cancer; 2019 May; 19(1):454. PubMed ID: 31092229
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive bioinformatics analysis of NOX4 as a biomarker for pan-cancer prognosis and immune infiltration.
Liu Y; Huang H; Yang X; Huang D; Wang X; Yuan M; Hong L
Aging (Albany NY); 2024 Apr; 16(8):7437-7447. PubMed ID: 38663913
[TBL] [Abstract][Full Text] [Related]
4. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
Front Immunol; 2021; 12():646523. PubMed ID: 33679809
[TBL] [Abstract][Full Text] [Related]
5. Direct activation of the human major vault protein gene by DNA-damaging agents.
Shimamoto Y; Sumizawa T; Haraguchi M; Gotanda T; Jueng HC; Furukawa T; Sakata R; Akiyama S
Oncol Rep; 2006 Mar; 15(3):645-52. PubMed ID: 16465425
[TBL] [Abstract][Full Text] [Related]
6. VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.
Xia X; Xu F; Dai D; Xiong A; Sun R; Ling Y; Qiu L; Wang R; Ding Y; Lin M; Li H; Xie Z
Biosci Rep; 2024 May; 44(5):. PubMed ID: 38639057
[TBL] [Abstract][Full Text] [Related]
7. Proteomic analyses identify major vault protein as a prognostic biomarker for fatal prostate cancer.
Ramberg H; Richardsen E; de Souza GA; Rakaee M; Stensland ME; Braadland PR; Nygård S; Ögren O; Guldvik IJ; Berge V; Svindland A; Taskén KA; Andersen S
Carcinogenesis; 2021 May; 42(5):685-693. PubMed ID: 33609362
[TBL] [Abstract][Full Text] [Related]
8. Major vault protein supports glioblastoma survival and migration by upregulating the EGFR/PI3K signalling axis.
Lötsch D; Steiner E; Holzmann K; Spiegl-Kreinecker S; Pirker C; Hlavaty J; Petznek H; Hegedus B; Garay T; Mohr T; Sommergruber W; Grusch M; Berger W
Oncotarget; 2013 Nov; 4(11):1904-18. PubMed ID: 24243798
[TBL] [Abstract][Full Text] [Related]
9. A systematic pan-cancer analysis identifies LDHA as a novel predictor for immunological, prognostic, and immunotherapy resistance.
Zhang Q; Luo Y; Qian B; Cao X; Xu C; Guo K; Wan R; Jiang Y; Wang T; Mei Z; Liu J; Lv C
Aging (Albany NY); 2024 May; 16(9):8000-8018. PubMed ID: 38709280
[TBL] [Abstract][Full Text] [Related]
10. Adipocytes promote breast cancer resistance to chemotherapy, a process amplified by obesity: role of the major vault protein (MVP).
Lehuédé C; Li X; Dauvillier S; Vaysse C; Franchet C; Clement E; Esteve D; Longué M; Chaltiel L; Le Gonidec S; Lazar I; Geneste A; Dumontet C; Valet P; Nieto L; Fallone F; Muller C
Breast Cancer Res; 2019 Jan; 21(1):7. PubMed ID: 30654824
[TBL] [Abstract][Full Text] [Related]
11. Hyperosmotic stress up-regulates the expression of major vault protein in SW620 human colon cancer cells.
Ikeda R; Iwashita K; Sumizawa T; Beppu S; Tabata S; Tajitsu Y; Shimamoto Y; Yoshida K; Furukawa T; Che XF; Yamaguchi T; Ushiyama M; Miyawaki A; Takeda Y; Yamamoto M; Zhao HY; Shibayama Y; Yamada K; Akiyama S
Exp Cell Res; 2008 Oct; 314(16):3017-26. PubMed ID: 18671966
[TBL] [Abstract][Full Text] [Related]
12. Expression of the Major Vault Protein (MVP) and Cellular Vault Particles in Fish.
Margiotta AL; Bain LJ; Rice CD
Anat Rec (Hoboken); 2017 Nov; 300(11):1981-1992. PubMed ID: 28710803
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value and immunological role of PDCD1 gene in pan-cancer.
Miao Y; Wang J; Li Q; Quan W; Wang Y; Li C; Wu J; Mi D
Int Immunopharmacol; 2020 Dec; 89(Pt B):107080. PubMed ID: 33069926
[TBL] [Abstract][Full Text] [Related]
14. Y-box binding protein 1 (YB-1) promotes gefitinib resistance in lung adenocarcinoma cells by activating AKT signaling and epithelial-mesenchymal transition through targeting major vault protein (MVP).
Lou L; Wang J; Lv F; Wang G; Li Y; Xing L; Shen H; Zhang X
Cell Oncol (Dordr); 2021 Feb; 44(1):109-133. PubMed ID: 32894437
[TBL] [Abstract][Full Text] [Related]
15. Pan-cancer analysis identifies RNF43 as a prognostic, therapeutic and immunological biomarker.
Xu Y; Lin Z; Ji Y; Zhang C; Tang X; Li C; Liu T
Eur J Med Res; 2023 Oct; 28(1):438. PubMed ID: 37848933
[TBL] [Abstract][Full Text] [Related]
16. Characterization of MVP and VPARP assembly into vault ribonucleoprotein complexes.
Zheng CL; Sumizawa T; Che XF; Tsuyama S; Furukawa T; Haraguchi M; Gao H; Gotanda T; Jueng HC; Murata F; Akiyama S
Biochem Biophys Res Commun; 2005 Jan; 326(1):100-7. PubMed ID: 15567158
[TBL] [Abstract][Full Text] [Related]
17. Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer.
Huang D; Shen J; Zhai L; Chen H; Fei J; Zhu X; Zhou J
Front Immunol; 2021; 12():812713. PubMed ID: 35069601
[TBL] [Abstract][Full Text] [Related]
18. Pan-cancer analysis reveals correlation between RAB3B expression and tumor heterogeneity, immune microenvironment, and prognosis in multiple cancers.
Liu XS; Chen YL; Chen YX; Wu RM; Tan F; Wang YL; Liu ZY; Gao Y; Pei ZJ
Sci Rep; 2024 Apr; 14(1):9881. PubMed ID: 38688977
[TBL] [Abstract][Full Text] [Related]
19. Alteration of major vault protein in human glioblastoma and its relation with EGFR and PTEN status.
Navarro L; Gil-Benso R; Megías J; Muñoz-Hidalgo L; San-Miguel T; Callaghan RC; González-Darder JM; López-Ginés C; Cerdá-Nicolás MJ
Neuroscience; 2015 Jun; 297():243-51. PubMed ID: 25869624
[TBL] [Abstract][Full Text] [Related]
20. MVP and vaults: a role in the radiation response.
Lara PC; Pruschy M; Zimmermann M; Henríquez-Hernández LA
Radiat Oncol; 2011 Oct; 6():148. PubMed ID: 22040803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
